Source: PIB Contents1 What is the News?2 About BBV154:3 About Mission COVID Suraksha 4 About BIRAC What is the News? BBV154, the first Nasal Vaccine against Covid-19 has received the regulator’s nod for conducting Phase 2 and 3 clinical trials. About BBV154: BBV154 is an intranasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine. It is the first… Continue reading First Nasal Vaccine Developed by Bharat Biotech supported by DBT-BIRAC gets nod of regulator for Phase 2 Trial
Tag: BBV154
Search Articles
Latest Articles
- 10 PM UPSC Current Affairs Quiz 5 July, 2024
- 9 PM UPSC Current Affairs Articles 5th July, 2024
- UPSC Prelims Marathon 5th July – Growth of revolutionary organizations in India and abroad – 2024
- Download EPIC! June 2024 – The Monthly Current Affairs Magazine by ForumIAS
- 10 PM UPSC Current Affairs Quiz 4 July, 2024
- 9 PM UPSC Current Affairs Articles 4th July, 2024
- Ethical issues and violations in medical trials in India
- UPSC Prelims Marathon 4th July – The Gandhian Era – II – 2024
- [Answered] UPSC Mains Answer Writing 3rd July 2024 I Mains Marathon
- 10 PM UPSC Current Affairs Quiz 3 July, 2024